Combinational therapy involving a small molecule inhibitor of the MDM2: P53 interaction

Details for Australian Patent Application No. 2006200853 (hide)

Owner Ortho-McNeil Pharmaceutical, Inc.

Inventors Lu, Tianbao; Koblish, Holly K.; Maroney, Anna

Agent Shelston IP

Pub. Number AU-A-2006200853

Priority 11/072391 04.03.05 US

Filing date 28 February 2006

Wipo publication date 21 September 2006

International Classifications

A61K 31/5513 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

16 March 2006 Complete Application Filed

  Priority application(s): 11/072391 04.03.05 US

21 September 2006 Application Open to Public Inspection

  Published as AU-A-2006200853

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200854-bd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it

2006200852-A method for producing an odour neutralisation substance